Garry Neil, Avalo Therapeutics CEO

Ava­lo Ther­a­peu­tics to lay off 33% of staff amidst mar­ket strug­gles and pen­ny stock sta­tus

Ava­lo Ther­a­peu­tics is con­tin­u­ing to hit bumps in its jour­ney as it is ex­e­cut­ing a work­force re­duc­tion to fo­cus more on its pipeline.

The Rockville …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.